Insight Share Price

Insight Share Price

NASDAQ: IMDX | Micro Cap | Healthcare
$1.97
+$0.32 (19.39%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Insight Stock Performance

Open
$1.75
Prev. Close
$1.65
Circuit Range
N/A
Day Range
$1.63 - $1.98
Year Range
$1.51 - $7.51
Volume
38,611
Average Traded
$1.83

Insight Share Price Today

As of 21 November 2026, Insight Molecular Diagnostics Inc.'s share price is $1.97. The stock opened at $1.75, compared to its previous close of $1.65. During today's trading session, Insight Molecular Diagnostics Inc.'s share price traded between $1.63 and $1.98, with an average price of $1.80. Over the past 52 weeks, the stock has recorded a high of $7.51 and a low of $1.51. In terms of performance, Insight Molecular Diagnostics Inc.'s share price has declined by 68.43% over the last six months and is down 67.81% on a year-on-year basis.

Insight Share Price Chart

Line chart of the Insight price trend over the selected period. The price rose overall, ranging from 1.63 to 1.98, ending at 1.97.
$1.63$1.98
L
Show Current Price
H

Insight Stock Fundamentals & Key Indicators

Market Cap
$60.04M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.03
Revenue (TTM)
$4.06B
Return On Equity (TTM)
174.07%
Profit Margin
-1236.95%
Debt to Equity
-0.02
Quarterly Earnings Growth YoY
84.41%

Insight Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$1.14$0.03$0.24$0.56
Net Profit-$22.96-$4.29-$11.26-$3.58
Net Profit Margin-2014.04%-14300.00%-4691.67%-639.29%
Income ChangeN/A81.32%-162.47%68.21%

Insight Annual Profit & Loss

All figures in USD

Particulars2025
Revenue$4.06
Net Profit-$50.22
Net Profit Margin-1236.95%
Income ChangeN/A

Insight Balance Sheet

All figures in USD Million

Particulars2025
Non Current Assets10.45
Current Assets15.31
Total Assets25.76
Non Current Liabilities45.15
Current Liabilities12.08
Total Liabilities57.22
Shareholders' Equity-31.46

Insight Cash Flow

Annually

All figures in USD Million

Particulars2025
Operating-22.18
Investing-3.19
Financing28.07

About Insight

Insight Molecular Diagnostics Inc is a pioneering diagnostics technology company whose mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. The Company's flagship technology quantifies a molecular biomarker known as donor-derived cell-free DNA (dd-cfDNA). It is also in the process of rebranding its RUO test kit, GraftAssure, as GraftAssureIQ, and rebranding its future in-vitro diagnostic (IVD) test kit as GraftAssureDx. The company geographically operates in the United States, the United Kingdom, Europe, and the Asia-Pacific regions, with maximum revenue generated from the USA.

Insight Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$2.97
$1.95
-34.34%
Oct 2026
$3.37
$2.97
-17.39%
Sep 2026
$3.82
$3.60
-15.81%
Aug 2026
$4.90
$4.27
-8.57%
Jul 2026
$5.74
$4.67
-20.03%
Jun 2026
$6.21
$5.84
-6.41%
May 2026
$3.99
$6.24
+57.58%
Apr 2026
$3.03
$3.96
+20.73%
Mar 2026
$5.83
$3.28
-45.24%
Feb 2026
$6.79
$5.99
-9.79%
Jan 2026
$7.27
$6.64
-11.58%
Dec 2025
$5.81
$7.51
+22.71%

Insight Share Price FAQs